Prostate Cancer
Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis.
January 11, 2023
Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer.
January 11, 2023
The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers.
January 10, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
January 10, 2023
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence.
January 10, 2023
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort.
January 10, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
January 9, 2023
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
January 9, 2023
Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program.
January 6, 2023
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
January 6, 2023
Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
January 6, 2023
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
January 6, 2023